Tumor control probability predictions for genetic radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 57, Issue 1, 2003, Pages 255-263

  Keall, Paul J ^a   Lammering, Guido ^a   Lin, Peck Sun ^a   Winter, David S ^a   Chung, Theodore D ^a   Mohan, Radhe ^a   Schmidt Ullrich, Rupert K ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Gene Therapy; Radiobiology; Radiotherapy; Tumor control probability

Indexed keywords

CELLS; GENES; TUMORS;

GENE THERAPY;

RADIOTHERAPY;

ARTICLE; BEAM THERAPY; BYSTANDER EFFECT; CANCER CONTROL; CANCER RADIOTHERAPY; GENE THERAPY; GENETIC RADIOTHERAPY; GENETIC TRANSDUCTION; HEAD CANCER; INTERMETHOD COMPARISON; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MULTIMODALITY CANCER THERAPY; NECK CANCER; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE;

EID: 0043066895     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00500-5     Document Type: Article

References (22)

1. Wheldon T.E. Radiation physics and genetic targeting New directions for radiotherapy. The Douglas Lea Lecture 1999 . Phys Med Biol. 45:2000;R77-R95.
2. Wheldon T.E., Mairs R.J., Rampling R.P., et al. Modelling the enhancement of fractionated radiotherapy by gene transfer to sensitize tumour cells to radiation. Radiother Oncol. 48:1998;5-13.
3. Jones B., Dale R.G. Inclusion of molecular biotherapies with radical radiotherapy Modeling of combined modality treatment schedules . Int J Radiat Oncol Biol Phys. 45:1999;1025-1034.
4. Jones B., Dale R.G. Radiobiological modeling and clinical trials. Int J Radiat Oncol Biol Phys. 48:2000;259-265.
5. Webb S. Optimum parameters in a model for tumour control probability including interpatient heterogeneity. Phys Med Biol. 39:1994;1895-1914.
6. Brenner D.J. Dose, volume, and tumor-control predictions in radiotherapy. Int J Radiat Oncol Biol Phys. 26:1993;171-179.
7. Fletcher G.H., Shukovsky L.J. The interplay of radiocurability and tolerance in the irradiation of human cancers. J Radiol Electrol Med Nucl. 56:1975;383-400.
8. Hall E.J., Cox J.D. Physical and biologic basis of radiation therapy. Cox J.D. Radiation oncology, Rationale, technique, results. 1989;1-57 The C.V. Mosby Company, St. Louis.
9. Munzenrider J.E., Brown A.P., Chu J.C.H., et al. Numerical scoring of treatment plans. Int J Radiat Oncol Biol Phys. 21:1991;147-163.
10. ICRU. ICRU Report 50. Prescribing, recording and reporting photon beam therapy. Bethesda, MD: International Commission on Radiation Units and Measurements; 1993.
11. Nguyen D.M., Wiehle S.A., Roth J.A., et al. Gene delivery into malignant cells in vivo by a conjugated adenovirus/DNA complex. Cancer Gene Ther. 4:1997;183-190.
12. Lammering G., Valerie K., Lin P.S., et al. Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor. Clin Cancer Res. 7:2001;682-690.
13. Lammering G., Lin P.S., Contessa J.N., et al. Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells. Int J Radiat Oncol Biol Phys. 51:2001;775-784.
14. Brenner D.J., Elliston C.D. The potential impact of bystander effects on radiation risks in a Mars mission. Radiat Res. 156:2001;612-617.
15. Brenner D.J., Little J.B., Sachs R.K. The bystander effect in radiation oncogenesis: II. A quantitative model. Radiat Res. 155:2001;402-408.
16. Lewis D.A., Mayhugh B.M., Qin Y., et al. Production of delayed death and neoplastic transformation in CGL1 cells by radiation-induced bystander effects. Radiat Res. 156:2001;251-258.
17. Mothersill C., Rea D., Wright E.G., et al. Individual variation in the production of a 'bystander signal' following irradiation of primary cultures of normal human urothelium. Carcinogenesis. 22:2001;1465-1471.
18. Mothersill C., Seymour C. Radiation-induced bystander effects Past history and future directions . Radiat Res. 155:2001;759-767.
19. Sawant S.G., Randers-Pehrson G., Metting N.F., et al. Adaptive response and the bystander effect induced by radiation in C3H 10T(1/2) cells in culture. Radiat Res. 156:2001;177-180.
20. Sawant S.G., Randers-Pehrson G., Geard C.R., et al. The bystander effect in radiation oncogenesis I. Transformation in C3H 10T1/2 cells in vitro can be initiated in the unirradiated neighbors of irradiated cells . Radiat Res. 155:2001;397-401.
21. Giles M.S., Smith P.G., Coletta P.L., et al. The herpesvirus saimiri ORF 73 regulatory region provides long-term transgene expression in human carcinoma cell lines. Cancer Gene Ther. 10:2003;49-56.
22. Li S., Simons J., Detorie N., et al. Dosimetric and technical considerations for interstitial adenoviral gene therapy as applied to prostate cancer. Int J Radiat Oncol Biol Phys. 55:2003;204-214.